Available until 12/31/2024 Quick registration 0.25 CME credits available Posted by Integrity Continuing Education on 2/5/2024
Homozygous familial hypercholesterolemia (HoFH) is a genetic disorder characterized by markedly elevated levels of low-density lipoprotein cholesterol (LDL-C), leading to premature cardiovascular dis.
Available until 1/6/2025 Quick registration 1.0 CE credit available (1.0 pharmacology) Posted by Louisiana Association of Nurse Practitioners on 1/30/2024
Unpacking Prenatal Nutrition:Key Nutrients, Supplementation, Pharmacotherapeutics & Maternal/Fetal Outcomes
Available until 5/25/2025 Quick registration 0.5 contact hours available Posted by Illinois Society for Advanced Practice Nursing on 1/11/2024
Breast Density and Screening - Routine Ultrasound and Mammogram?
Available until 1/26/2025 Quick registration 0.85 contact hours available Posted by Illinois Society for Advanced Practice Nursing on 1/11/2024
Important Warning Signs of Mental Illness
Available until 5/25/2025 Quick registration 1.0 contact hour available Posted by Illinois Society for Advanced Practice Nursing on 1/11/2024
Acute and Chronic Wounds: The Basics and Beyond
Available until 12/14/2024 1.0 contact hour available (0.52 pharmacology) Posted by Prime CE on 1/8/2024
Advances in our understanding of the pathogenesis and pathophysiology of multiple sclerosis have led to the discovery of novel treatment targets for this disease, including Bruton's tyrosine kinase.
Available until 12/14/2024 1.0 contact hour available Posted by Prime CE on 1/7/2024
Join us for an expert-led discussion of strategies to promote health equity in stroke care.
Available until 11/28/2024 0.5 contact hours available (0.35 pharmacology) Posted by Prime CE on 1/7/2024
Join us for this on-demand video as an expert oncologist and surgeon highlight insights learned from a recent multidisciplinary tumor board-based quality improvement program.
Available until 11/28/2024 0.75 contact hours available (0.6 pharmacology) Posted by Prime CE on 1/7/2024
Join us for an exciting discussion by two renowned renal cell carcinoma (RCC) experts as they delve deep into the dynamic world of RCC.
Available until 11/27/2024 1.0 contact hour available (0.56 pharmacology) Posted by Prime CE on 1/7/2024
Novel and emerging biomarkers are improving outcomes for patients with colorectal cancer (CRC). Tune in for a comprehensive discussion on the latest advances in biomarker-directed therapy for CRC.